The understanding of the pathophysiology of atherosclerosis and related vascular diseases has changed over the last decade, providing new perspectives for preventive and therapeutic strategies.

Although experimental work has helped to unravel some of the principles of atherosclerosis pathophysiology, gaps remain in translation to the clinic, and these breeches require bridging to achieve ...

The pathophysiology of intermittent claudication ... PVD is a sign of generalized atherosclerosis and increases the risk of cardiac morbidity and mortality. Smoking, hypertension, diabetes ...

Atherosclerosis happens when arteries become narrow and hard due to a buildup of plaque around the artery wall. Atherosclerosis can lead to a heart attack, stroke, and other complications. Other ...

How Does Atherosclerosis Relate to High Blood Pressure? Atherosclerosis is plaque buildup in the arteries. When it occurs in the arteries that supply blood to the heart, doctors call it ...

Atherosclerosis is the buildup of plaque — a combination of cholesterol, fat, calcium, and blood elements — on and inside the walls of your arteries. Your arteries are the blood vessels that ...

Prior to 1990, many assumed that once cholesterol plaques form in the arteries causing atherosclerosis, it was not reversible. While this is true for plaques that have calcified, what about ...

You can’t reverse atherosclerosis, but certain medications, dietary changes, and surgery can help to slow its progression and reduce your risk of complications. Atherosclerosis, more commonly ...

Share on Pinterest Experts note that atherosclerosis is linked to heart disease risk. Susana Ramírez/Stocksy The medication saracatinib has been researched in the past as a potential cancer ...

A drug candidate, previously successful at treating severe fatty liver disease, reduces atherosclerosis—a primary driver of cardiovascular death worldwide—in large mammals, a study suggests.

"Atherosclerosis usually starts in the teens and 20s, and by the 30s we can see changes in most people," says cardiologist Matthew Sorrentino MD, a professor at The University of Chicago Medicine.